Health

India’s Bharat Biotech gets official approval to test nasal COVID-19 shot as booster

India vaccine manufacturer Bharat Biotech on Wednesday got ‘in principle’ approval from the country’s drug regulator to test nasal COVID-19 vaccine as a booster shot.
The drug regulator DCGI granted approval to Hyderabad-based Bharat Biotech for conducting late-stage trials of its nasal COVID-19 vaccine to be used as a booster shot, according to news agency ANI.

Read the latest updates in our dedicated coronavirus section.

Meanwhile, India on Wednesday reported 58,097 new COVID-19 cases, 124 deaths in last 24 hours. The government said that the country has reported 2,135 omicron cases so far.

For the latest headlines, follow our Google News channel online or via the app.

Health

World News in Brief: Vaccine ‘patches’ trial shows promise, lowering catheter infection risk, Guantanamo detainee facing revictimisation

Few enjoy having injections and if you have children, you probably like them even less when it’s time for their mandated vaccine shots.

Health

No sign yet of H5N1 bird flu spreading between humans, says WHO chief

The H5N1 avian influenza virus has so far shown no signs of adapting to allow human to human transmission, the UN health agency said on Wednesday, urging continued surveillance.

Health

Patients in Rafah ‘afraid to seek services’, WHO reports

The World Health Organization (WHO) has taken “crucial steps” in the event of a large-scale Israeli military operation in Rafah, Dr. Ahmed Dahir, Team Lead of its office in Gaza, told UN News on Tuesday.